Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Comments for:

Into the depths of ataxia
Harry T. Orr
Harry T. Orr
Published February 15, 2004
Citation Information: J Clin Invest. 2004;113(4):505-507. https://doi.org/10.1172/JCI21092.
View: Text | PDF
Commentary

Into the depths of ataxia

  • Text
  • PDF
Abstract

Ataxia is a lethal neurological disease characterized by incoordination, postural abnormalities, difficulties with gait, and problems with clarity of speech. The etiology of ataxia is divided equally between hereditary and sporadic forms. Regardless of cause, the cerebellar cortex is often a target in ataxia. Thus, how a disruption in cerebellar cortex might lead to ataxia is of considerable interest. A report in this issue of the JCI links ataxia to enhanced hyperexcitability of neurons in the deep cerebellar nuclei.

Authors

Harry T. Orr

×

Is ataxia lethal?

Submitter: Dirk Ulbricht | ulbricht@macnews.de

Service de Neurologie, Hôpital de la Ville Esch-sur-Alzette, Luxembourg

Published February 18, 2004

Dr. Orr states that "...ataxia is a lethal neurological disease...“. This is wrong. Ataxia is a symptom of disease. The origin is primarily defined on clinical grounds with an anatomical hypothesis in mind, and the time course is used to define the probable cause. A difference can be made between cerebellar and spinal ataxia, the latter typically originating from lesions to the posterior column of the spinal cord, e.g. in case of Vitamin B12 deficiency. There are other symptoms called ataxia, but this is not nequivocal in the literature. It is also noteworthy that cerebellar ataxia arising from stroke, from MS, or from the residual damage of infantile neuroblastoma carries a usually benign prognosis. There is also a mixed ataxia when simply drinking a little bit too much, which is usually fairly well compatible with life. As the first sentence of the abstract, this leads the clinician to a somewhat suspicious attitude to the otherwise excellent editorial.

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts